TECH Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TECH shares is 830, representing 99.46% of the company's common stock.

HANDELSBANKEN FONDER AB, in the last quarter, reduced its stake in TECH by -7.44% restricting it's holding to 373.15 thousand shares of worth nearly $26.27M. MONTANARO ASSET MANAGEMENT LTD also lessened -17.25% of the TECH shares from its portfolio, reducing its holding to 302.3 thousand shares of worth $21.28M. PEMBROKE MANAGEMENT, LTD also shunned TECH shares holding by -22.5% last quarter which brought its holding to 283.26 thousand shares worth $19.94M.

As per its latest 13F filing, PRICE T ROWE ASSOCIATES INC /MD/ increased its stake in TECH by 92.11% in the last quarter. The institutional holder raised its holding to 5.75 million shares having worth more than $404.47M. CRAMER ROSENTHAL MCGLYNN LLC also added 63.24% more shares of TECH to its portfolio, raising its holding to 380.8 thousand shares of worth $26.80M. RAYMOND JAMES & ASSOCIATES also increased its TECH shares holding by 11.96% which brought its holding to 334.19 thousand shares worth $23.52M.

The insider with the most stakes in TECH is Kummeth Charles R. , Chief Executive Officer at the company. Additionally, TECH stock is highly held by director BAUMGARTNER ROBERT V and director Nusse Roeland among others.

Company executives, directors, and other insiders own 1.04% percent of Bio-Techne Corporation's stock. Within the last six months, there have been 1 transaction(s) in which TECH insiders have sold stock, totaling 16K shares. Insiders that have sold shares include BAUMGARTNER ROBERT V, HIGGINS JOHN L, and NUSSE ROELAND.

There have been 0 transaction(s) during the past 6-months in which Bio-Techne Corporation insiders have bought stock, totalling 0 shares

Around 43.4K Bio-Techne Corporation shares are held by insiders, which represents about 1.04% of TECH stock.

TECH Chief Executive Officer, Kummeth Charles R. holds the largest portfolio of the company's shares. TECH shares owned by Kummeth total nearly 1.26 million.

PRICE T ROWE ASSOCIATES INC /MD/ is the largest institutional owner in TECH which holds 5.75 million shares worth $404.47M or 3.65% of the total TECH shares outstanding followed by CRAMER ROSENTHAL MCGLYNN LLC with ownership of 380.8 thousand shares representing 0.24% of the TECH ownership. HANDELSBANKEN FONDER AB is the third largest stakeholder with 373.15 thousand shares or 0.24% of the ownership worth more than $26.27M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TECH is concerned, it is a stock which is optionable.

Number of TECH shares short is 3.77M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 158.89M shares of TECH are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TECH has 157.08M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TECH is 5.42.